Skip to main content
. Author manuscript; available in PMC: 2019 Aug 7.
Published in final edited form as: J Heart Valve Dis. 2014 Nov;23(6):713–720.

Table I:

Hemodynamic data.

Hemodynamic parameter Baseline 30 min post MI Eight weeks after MI
Resting 5 μg/kg/min Dobutamine 10 μg/kg/min Dobutamine
Systolic ABP (mmHg) 89.0 ± 9.6 81.1 ± 9.3a 88.1 ± 9.9 97.8 ± 12.9b 99.6 ± 14.9b
Systolic PAP (mmHg) 29.2 ± 4.6 31.2 ± 7.8 35.1 ± 2.3a 35.8 ± 3.0 37.2 ± 2.0b
Maximum dP/dt (mmHg/s) 909 ± 244 988 ± 464 840 ± 158d 1529 ± 377a,b,c 2284 ± 436a,b,c,d
Minimum dP/dt (mmHg/s) −1151 ± 257 −986 ± 473 −963 ± 159a −1251 ± 221 −1646 ± 495a,b,c
PCWP (mmHg) 13.7 ± 3.3 17.1 ± 6.7a 20.3 ± 3.8a 20.3 ± 3.5a 18.3 ± 3.7a
CVP (mmHg) 11.4 ± 4.4 11.6 ± 3.9 17.3 ± 3.5a,b 16.7 ± 2.6a,b 14.0 ± 3.2
Cardiac output (1/min) 3.5 ± 1.0 3.1 ± 0.6 4.5 ± 1.6b 7.1 ± 2.4a,b,c 6.7 ± 1.9a,b,c

All values are mean ± SD.

ABP: Arterial blood pressure; CVP: Central venous pressure; MI: Myocardial infarction; PAP: Pulmonary artery pressure; PCWP: Pulmonary capillary wedge pressure.

a

p <0.05 versus baseline;

b

p <0.05 versus 30 min after MI;

c

p <0.05 versus resting condition;

d

p <0.05 versus dobutamine 5 μg/kg/min.